Nuvectis Pharma, Inc. (NVCT) ROE
- 2026-06-30: ROE -306.61%.
- 2026-03-31: ROE -191.00%.
- 2025-12-31: ROE -143.61%.
- 2025-09-30: ROE -105.69%.
Complete source-backed roe history.
- Available history
- 2021-12-31 to 2026-06-30
- Data captured
Historical ROE
| Date | ROE |
|---|
| 2026-06-30 | -306.61% |
|---|
| 2026-03-31 | -191.00% |
|---|
| 2025-12-31 | -143.61% |
|---|
| 2025-09-30 | -105.69% |
|---|
| 2025-06-30 | -130.79% |
|---|
| 2025-03-31 | -96.22% |
|---|
| 2024-12-31 | -195.61% |
|---|
| 2024-09-30 | -176.27% |
|---|
| 2024-06-30 | -168.44% |
|---|
| 2024-03-31 | -159.62% |
|---|
| 2023-12-31 | -182.44% |
|---|
| 2023-09-30 | -133.85% |
|---|
| 2023-06-30 | -109.83% |
|---|
| 2023-03-31 | -164.50% |
|---|
| 2022-12-31 | -134.22% |
|---|
| 2022-09-30 | -71.91% |
|---|
| 2022-06-30 | -116.88% |
|---|
| 2022-03-31 | -108.59% |
|---|
| 2021-12-31 | 117.10% |
|---|
Annual ROE
| Date | ROE |
|---|
| 2025-12-31 | -143.61% |
|---|
| 2024-12-31 | -195.61% |
|---|
| 2023-12-31 | -182.44% |
|---|
| 2022-12-31 | -134.22% |
|---|
| 2021-12-31 | 117.10% |
|---|